DCF — ADVENTHEALTH ZEPHYRHILLS
Enterprise Value: $-62.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-62.5M
Enterprise Value
$-25.6M
PV of Cash Flows
$-36.9M
PV of Terminal Value
$-59.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $213.3M | $-0.7M | -0.0% | $-9.7M | $-8.8M |
| Year 2 | $219.7M | $1.5M | 1.0% | $-7.8M | $-6.5M |
| Year 3 | $226.3M | $3.8M | 2.0% | $-5.8M | $-4.4M |
| Year 4 | $233.1M | $5.1M | 2.0% | $-4.8M | $-3.3M |
| Year 5 | $240.1M | $5.8M | 2.0% | $-4.3M | $-2.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-62.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$207.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.00826138842499885
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5